Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
International Immunology|October 31, 2002
A regulatory role for suppressor of cytokine signaling-1 in T(h) polarization in vivoMinoru Fujimoto, Hiroko Tsutsui, Shizue Yumikura-Futatsugi, et al.
Pigment Cell & Melanoma Research|December 6, 2011
Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgarisYorihisa Kotobuki, Atsushi Tanemura, Lingli Yang, et al.
Experimental Dermatology|July 16, 2015
Suppressor of cytokine signalling-1 induces significant preclinical antitumor effect in malignant melanoma cellsNaoko Tagami-Nagata, Satoshi Serada, Minoru Fujimoto, et al.
Plos One|August 23, 2012
Periostin facilitates skin sclerosis via PI3K/Akt dependent mechanism in a mouse model of sclerodermaLingli Yang, Satoshi Serada, Minoru Fujimoto, et al.
Biochemical and Biophysical Research Communications|February 15, 2005
Suppressor of cytokine signaling 1 suppresses muscle differentiation through modulation of IGF-I receptor signal transductionMakiko Inaba, Hiroshi Saito, Minoru Fujimoto, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 19, 2010
Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociationHidetaka Akita, Kentaro Kogure, Rumiko Moriguchi, et al.
The American Journal of Pathology|November 9, 2011
Blockade of interleukin-6 receptor alleviates disease in mouse model of sclerodermaShun Kitaba, Hiroyuki Murota, Mika Terao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 10, 2010
Reprint of: Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: Programmed endosomal escape and dissociationHidetaka Akita, Kentaro Kogure, Rumiko Moriguchi, et al.
International Journal of Cancer|April 26, 2012
SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesotheliomaKota Iwahori, Satoshi Serada, Minoru Fujimoto, et al.
Pageof 11